GlassScriptPhysician profile
Robert Andrews Bass
NPI 1003957952
$9,023.89
in general payments reported to CMS, 2019-2025
44 companies · $2,791 in 2025
The $2,791 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983 · 2020: $272 · 2021: $494 · 2022: $809 · 2023: $2,475 · 2024: $1,199 · 2025: $2,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,037 · Travel and Lodging: $1,329 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,036.90 |
| Travel and Lodging | $1,328.97 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,028.01 | 2019-2025 | Ams 700, Lithovue, Advantage System |
| Angiodynamics, INC. | $1,311.34 | 2023-2025 | Nanoknife |
| Astellas Pharma US INC | $827.53 | 2019-2023 | Myrbetriq, Veozah |
| Coloplast Corp | $517.64 | 2019-2024 | Speedicath |
| Abbvie INC. | $510.51 | 2020-2025 | Lupron Depot, Botox |
| Janssen Biotech, INC. | $458.61 | 2023-2025 | Erleada, Akeega, Balversa |
| C. R. Bard, INC. & Subsidiaries | $389.85 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Rochester Medical Corporation | $284.79 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $275.45 | 2023-2025 | Gemtesa |
| Srs Medical Systems, INC. | $250.00 | 2023 | Urocuff |
| Medtronic, INC. | $185.68 | 2023-2025 | Interstim |
| Dendreon Pharmaceuticals LLC | $178.69 | 2019 | |
| Endo USA, INC. | $152.55 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $133.99 | 2019-2024 | Xiaflex, Aveed |
| Stryker Corporation | $132.44 | 2022-2025 | 1788 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $120.24 | 2021-2025 | Jelmyto |
| Procept Biorobotics Corporation | $115.76 | 2022-2025 | Aquabeam System |
| Urovant Sciences INC | $94.50 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $92.61 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Allergan, INC. | $88.54 | 2019-2022 | |
| Intuitive Surgical, INC. | $83.82 | 2023 | Da Vinci Surgical System |
| Olympus America INC. | $65.64 | 2020-2023 | Itind System |
| Calyxo, INC. | $59.47 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $56.84 | 2019 | |
| Valencia Technologies Corporation | $55.56 | 2025 | Ecoin Device Kit |
| Edap Technomed INC | $54.00 | 2024 | |
| Convatec INC. | $53.13 | 2025 | |
| Myriad Genetic Laboratories, INC. | $50.00 | 2025 | Prolaris |
| Axonics, INC. | $41.91 | 2021-2022 | |
| 180 Medical, INC. | $41.82 | 2021-2024 | |
| Mission Pharmacal Company | $40.96 | 2023-2024 | Uribel Tabs |
| Progenics Pharmaceuticals, INC. | $38.49 | 2023 | Pylarify |
| Ethicon US, LLC | $28.31 | 2019 | |
| Tolmar, INC. | $27.24 | 2025 | Eligard, Jatenzo |
| Ferring Pharmaceuticals INC. | $24.88 | 2025 | Adstiladrin |
| Neotract INC. | $24.21 | 2019 | |
| Travere Therapeutics, INC. | $20.52 | 2019 | |
| Accord Healthcare, INC. | $18.40 | 2024 | |
| Clarus Therapeutics INC. | $16.86 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.61 | 2021 | |
| Myovant Sciences INC. | $15.97 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.36 | 2023 | Seglentis |
| Baxter Healthcare | $14.25 | 2019 | |
| Cook Medical LLC | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.